Ryan, speaking at a social media event, said that if needed, however, the work was already underway in case Omicron-specific vaccines were needed.
"Right now, we have highly effective vaccines that are working. We need to focus on getting them more equitably distributed. We need to focus on getting people most at risk vaccinated," Ryan said.
The agency said earlier on Friday that it was still studying the transmissibility and severity of the new variant.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the ET ePaper online.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the ET ePaper online.